The global Pulmonary Function Testing Systems market size was valued at US$ 446 million in 2024 and is forecast to a readjusted size of USD 589 million by 2031 with a CAGR of 4.1% during review period.
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.
This report is a detailed and comprehensive analysis for global Pulmonary Function Testing Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pulmonary Function Testing Systems market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pulmonary Function Testing Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pulmonary Function Testing Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pulmonary Function Testing Systems market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Function Testing Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Function Testing Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Pulmonary Function Testing Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Portable PFT Systems
Complete PFT Systems
麻豆原创 segment by Application
Hospitals
Physical Examination Center
Physician Groups
Others
Major players covered
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Function Testing Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Function Testing Systems, with price, sales quantity, revenue, and global market share of Pulmonary Function Testing Systems from 2020 to 2025.
Chapter 3, the Pulmonary Function Testing Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Function Testing Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pulmonary Function Testing Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Function Testing Systems.
Chapter 14 and 15, to describe Pulmonary Function Testing Systems sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Pulmonary Function Testing Systems Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Portable PFT Systems
1.3.3 Complete PFT Systems
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Pulmonary Function Testing Systems Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Physical Examination Center
1.4.4 Physician Groups
1.4.5 Others
1.5 Global Pulmonary Function Testing Systems 麻豆原创 Size & Forecast
1.5.1 Global Pulmonary Function Testing Systems Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pulmonary Function Testing Systems Sales Quantity (2020-2031)
1.5.3 Global Pulmonary Function Testing Systems Average Price (2020-2031)
2 Manufacturers Profiles
2.1 CareFusion(BD)
2.1.1 CareFusion(BD) Details
2.1.2 CareFusion(BD) Major Business
2.1.3 CareFusion(BD) Pulmonary Function Testing Systems Product and Services
2.1.4 CareFusion(BD) Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 CareFusion(BD) Recent Developments/Updates
2.2 Schiller
2.2.1 Schiller Details
2.2.2 Schiller Major Business
2.2.3 Schiller Pulmonary Function Testing Systems Product and Services
2.2.4 Schiller Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Schiller Recent Developments/Updates
2.3 CHEST
2.3.1 CHEST Details
2.3.2 CHEST Major Business
2.3.3 CHEST Pulmonary Function Testing Systems Product and Services
2.3.4 CHEST Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 CHEST Recent Developments/Updates
2.4 COSMED
2.4.1 COSMED Details
2.4.2 COSMED Major Business
2.4.3 COSMED Pulmonary Function Testing Systems Product and Services
2.4.4 COSMED Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 COSMED Recent Developments/Updates
2.5 nSpire Health
2.5.1 nSpire Health Details
2.5.2 nSpire Health Major Business
2.5.3 nSpire Health Pulmonary Function Testing Systems Product and Services
2.5.4 nSpire Health Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 nSpire Health Recent Developments/Updates
2.6 NDD
2.6.1 NDD Details
2.6.2 NDD Major Business
2.6.3 NDD Pulmonary Function Testing Systems Product and Services
2.6.4 NDD Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 NDD Recent Developments/Updates
2.7 MGC Diagnostics
2.7.1 MGC Diagnostics Details
2.7.2 MGC Diagnostics Major Business
2.7.3 MGC Diagnostics Pulmonary Function Testing Systems Product and Services
2.7.4 MGC Diagnostics Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 MGC Diagnostics Recent Developments/Updates
2.8 Minato
2.8.1 Minato Details
2.8.2 Minato Major Business
2.8.3 Minato Pulmonary Function Testing Systems Product and Services
2.8.4 Minato Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Minato Recent Developments/Updates
2.9 Ganshorn
2.9.1 Ganshorn Details
2.9.2 Ganshorn Major Business
2.9.3 Ganshorn Pulmonary Function Testing Systems Product and Services
2.9.4 Ganshorn Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Ganshorn Recent Developments/Updates
2.10 AESRI
2.10.1 AESRI Details
2.10.2 AESRI Major Business
2.10.3 AESRI Pulmonary Function Testing Systems Product and Services
2.10.4 AESRI Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 AESRI Recent Developments/Updates
2.11 Morgan Scientific
2.11.1 Morgan Scientific Details
2.11.2 Morgan Scientific Major Business
2.11.3 Morgan Scientific Pulmonary Function Testing Systems Product and Services
2.11.4 Morgan Scientific Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Morgan Scientific Recent Developments/Updates
2.12 M&B
2.12.1 M&B Details
2.12.2 M&B Major Business
2.12.3 M&B Pulmonary Function Testing Systems Product and Services
2.12.4 M&B Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 M&B Recent Developments/Updates
2.13 Sikeda
2.13.1 Sikeda Details
2.13.2 Sikeda Major Business
2.13.3 Sikeda Pulmonary Function Testing Systems Product and Services
2.13.4 Sikeda Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Sikeda Recent Developments/Updates
2.14 RSDQ
2.14.1 RSDQ Details
2.14.2 RSDQ Major Business
2.14.3 RSDQ Pulmonary Function Testing Systems Product and Services
2.14.4 RSDQ Pulmonary Function Testing Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 RSDQ Recent Developments/Updates
3 Competitive Environment: Pulmonary Function Testing Systems by Manufacturer
3.1 Global Pulmonary Function Testing Systems Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pulmonary Function Testing Systems Revenue by Manufacturer (2020-2025)
3.3 Global Pulmonary Function Testing Systems Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Pulmonary Function Testing Systems by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Pulmonary Function Testing Systems Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Pulmonary Function Testing Systems Manufacturer 麻豆原创 Share in 2024
3.5 Pulmonary Function Testing Systems 麻豆原创: Overall Company Footprint Analysis
3.5.1 Pulmonary Function Testing Systems 麻豆原创: Region Footprint
3.5.2 Pulmonary Function Testing Systems 麻豆原创: Company Product Type Footprint
3.5.3 Pulmonary Function Testing Systems 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pulmonary Function Testing Systems 麻豆原创 Size by Region
4.1.1 Global Pulmonary Function Testing Systems Sales Quantity by Region (2020-2031)
4.1.2 Global Pulmonary Function Testing Systems Consumption Value by Region (2020-2031)
4.1.3 Global Pulmonary Function Testing Systems Average Price by Region (2020-2031)
4.2 North America Pulmonary Function Testing Systems Consumption Value (2020-2031)
4.3 Europe Pulmonary Function Testing Systems Consumption Value (2020-2031)
4.4 Asia-Pacific Pulmonary Function Testing Systems Consumption Value (2020-2031)
4.5 South America Pulmonary Function Testing Systems Consumption Value (2020-2031)
4.6 Middle East & Africa Pulmonary Function Testing Systems Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Pulmonary Function Testing Systems Sales Quantity by Type (2020-2031)
5.2 Global Pulmonary Function Testing Systems Consumption Value by Type (2020-2031)
5.3 Global Pulmonary Function Testing Systems Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Pulmonary Function Testing Systems Sales Quantity by Application (2020-2031)
6.2 Global Pulmonary Function Testing Systems Consumption Value by Application (2020-2031)
6.3 Global Pulmonary Function Testing Systems Average Price by Application (2020-2031)
7 North America
7.1 North America Pulmonary Function Testing Systems Sales Quantity by Type (2020-2031)
7.2 North America Pulmonary Function Testing Systems Sales Quantity by Application (2020-2031)
7.3 North America Pulmonary Function Testing Systems 麻豆原创 Size by Country
7.3.1 North America Pulmonary Function Testing Systems Sales Quantity by Country (2020-2031)
7.3.2 North America Pulmonary Function Testing Systems Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Pulmonary Function Testing Systems Sales Quantity by Type (2020-2031)
8.2 Europe Pulmonary Function Testing Systems Sales Quantity by Application (2020-2031)
8.3 Europe Pulmonary Function Testing Systems 麻豆原创 Size by Country
8.3.1 Europe Pulmonary Function Testing Systems Sales Quantity by Country (2020-2031)
8.3.2 Europe Pulmonary Function Testing Systems Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Pulmonary Function Testing Systems Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pulmonary Function Testing Systems Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pulmonary Function Testing Systems 麻豆原创 Size by Region
9.3.1 Asia-Pacific Pulmonary Function Testing Systems Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pulmonary Function Testing Systems Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Pulmonary Function Testing Systems Sales Quantity by Type (2020-2031)
10.2 South America Pulmonary Function Testing Systems Sales Quantity by Application (2020-2031)
10.3 South America Pulmonary Function Testing Systems 麻豆原创 Size by Country
10.3.1 South America Pulmonary Function Testing Systems Sales Quantity by Country (2020-2031)
10.3.2 South America Pulmonary Function Testing Systems Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Pulmonary Function Testing Systems Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pulmonary Function Testing Systems Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pulmonary Function Testing Systems 麻豆原创 Size by Country
11.3.1 Middle East & Africa Pulmonary Function Testing Systems Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pulmonary Function Testing Systems Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Pulmonary Function Testing Systems 麻豆原创 Drivers
12.2 Pulmonary Function Testing Systems 麻豆原创 Restraints
12.3 Pulmonary Function Testing Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pulmonary Function Testing Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pulmonary Function Testing Systems
13.3 Pulmonary Function Testing Systems Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pulmonary Function Testing Systems Typical Distributors
14.3 Pulmonary Function Testing Systems Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
听
听
*If Applicable.
